HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Nguyen, C. L. Articles by Goldberg, M. Search for Related Content PubMed PubMed Citation Articles by Nguyen, C. L. Articles by Goldberg, M.

Radiofrequency Ablation of Primary Lung Cancer^*

Results From an Ablate and Resect Pilot Study

^* From the Departments of Surgical Oncology (Drs. Nguyen, Scott, Giles, and Goldberg) and Pathology (Dr. Young and Ms. Rader), Fox Chase Cancer Center, Philadelphia, PA.

Correspondence to: Walter J. Scott, MD, FCCP, Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Ave, Room C-308, Philadelphia, PA 19111-2497; e-mail: walter.scott{at}fccc.edu

Study objectives: The role of radiofrequency ablation (RFA) for primary lung cancer remains poorly defined. The purpose of this "ablate and resect" pilot study was to evaluate the safety of performing RFA in patients with primary non-small cell lung cancer (NSCLC) and to characterize the histologic changes in tumor tissue following such ablation.

Design: This prospective study was undertaken at a single institution, and 10 patients were accrued from June 2002 to June 2003. Eligible patients included those with clinical stage I or II disease. RFA of the tumor was performed through a standard thoracotomy followed by conventional lobectomy and lymph node dissection. Extent of cell death was determined histologically.

Measurements and results. Following the exclusion of two patients, the treated portions of eight tumors were examined for tumor cell viability. Gross inspection and routine histologic staining could not reliably identify the "immediately ablated" tissue. However, using a supravital staining technique, the treated areas from seven of the eight tumors (87.5%) demonstrated > 80% nonviability (100% nonviability was noted in the treated areas from three of the eight tumors). No bleeding or thermal complications were noted at the time of RFA, and none of the patients had skin burns at the electrode dispersive pad sites.

Conclusions: RFA of primary NSCLC is feasible and can be performed safely in the setting of an open thoracotomy. Complete tumor cell necrosis, as determined by supravital staining, was noted in the treated areas from three of eight tumors (37.5%). Such complete ablation was observed in the treated areas from smaller tumors (< 2 cm), whereas the treated areas from larger tumors demonstrated incomplete ablation. Additional investigation with histopathologic correlation is needed to fully assess the long-term efficacy of RFA for NSCLC.

Key Words: lung cancer • pathology, lung • radiology intervention • surgery

This article has been cited by other articles:

				N. Avril 18F-FDG PET After Radiofrequency Ablation: Is Timing Everything? J. Nucl. Med., August 1, 2006; 47(8): 1235 - 1237. [Full Text] [PDF]

				M. C. Ambrogi, G. Fontanini, R. Cioni, P. Faviana, O. Fanucchi, and A. Mussi Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: Results of a pilot study J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1002 - 1006. [Abstract] [Full Text] [PDF]